- Oct 01, 2024
-
-
Pan Zhao authored
修改了主页的Additionally, we recognize that abdominal infections are a significant cause of recurrent hepatic encephalopathy and can lead to death[1][2]. In response, we aim to develop an engineered bacterium capable of resisting inflammation and repairing the intestinal barrier. 文本
-
Pan Zhao authored
修改了主页的Conversely, there is a risk of excessive proliferation of the engineered E. coli within the human body, necessitating the development of controllable switches to regulate bacterial growth and death effectively. 文本
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Yijingxuan Duan authored
-
Xingan Zhao authored
-
Yijingxuan Duan authored
-
-
Xingan Zhao authored
-
Wu Zhiling authored
-
Yijingxuan Duan authored
-
Xingan Zhao authored
-
-
Xingan Zhao authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wan LI authored
-
Wu Zhiling authored
-
Wan LI authored
-
Wan LI authored
-
Wu Zhiling authored
-
Wu Zhiling authored
-
Wan LI authored
-
Wan LI authored
-
Wu Zhiling authored
-
Xingan Zhao authored
-
-
Xingan Zhao authored
-
Wu Zhiling authored
-
Xingan Zhao authored
-
Xingan Zhao authored
-
-
Xingan Zhao authored
-